We are deeply saddened by the loss of Dr. Bakris, whose dedication and contributions to CMHC as a renowned expert, educator, and mentor in the cardiorenal metabolic space have left an indelible mark on our community.
In honor of his memory, the upcoming Annual Cardiometabolic Health Congress will celebrate his life and legacy.
Join Cardiometabolic Health Congress (CMHC) in Boston in 2024 for the pinnacle of cardiometabolic health education. The 19th Annual CMHC will welcome hundreds of providers to learn strategies for translating the year’s latest advances directly to patient care.
On Oct. 17-19, 2024, The Cardiometabolic Event of the Yearâ„¢ will return to the Boston Park Plaza for an agenda packed with expert insights, patient case studies, late-breaking trial data, updates from industry, opportunities to network, and much more!
By registering for the 19th Annual CMHC, you are demonstrating your commitment to delivering evidence-based, whole-patient cardiometabolic care. You – and hundreds of your most forward-thinking colleagues – will return home on Monday with a restocked toolkit of therapies and strategies to address even the most complicated clinical cases.
Cardiometabolic Health Congress Chairs
Cardiometabolic Health Congress Senior Planning Committee
Cardiometabolic Health Congress Conference faculty
AGENDA
6:45 AM – 7:45 AM | PME Breakfast Symposium (non-CME) Attention on MASH: The Hepatic Manifestation of the Metabolic Syndrome Sponsored by Novo Nordisk. Steven L. Flamm, MD, FAASLD, FACG | |
FDA Update and Keynote | ||
7:45 AM – 8:00 AM | Refresh and Recharge – Exhibit Hall Break | |
8:00 AM – 8:15 AM | A Tribute to George Bakris | |
8:15 AM – 10:15 AM | FDA Update and Late Breaking Trials Moderator: Christie M. Ballantyne, MD Presenters: Deepak L. Bhatt, MD; Robert H. Eckel, MD; Keith C. Ferdinand, MD; Anne L. Peters, MD | |
10:15 AM – 10:45 AM | KEYNOTE Prevention and Treatment of Atherosclerosis Peter Libby, MD | |
10:45 AM – 11:15 AM | Exhibit Hall Break | |
11:15 AM – 12:15 PM | PME Lunch Symposium (non-CME)
Perspectives in Hyperglycemia Secondary to Hypercortisolism – A Path to Diagnosis Sponsored by Corcept Therapeutics. Davida F. Kruger, MSN, APN-BC,BC-ADM; Jay Shubrook, DO, FAAFP, FACOFP | |
12:15 PM – 12:45 PM | Exhibit Hall Break | |
12:45 PM – 12:50 PM | Opening Remarks Keith C. Ferdinand, MD | |
12:50 PM – 1:20 PM | Current and Emerging Therapies for Resistant Hypertension Supported by an educational grant from Recor Medical. Keith C. Ferdinand, MD | |
1:20 PM – 1:40 PM | Albuminuria Change as a Marker for CKD Progression Ajay K. Singh, MBBS, FRCP, MBA | |
1:40 PM – 2:00 PM | Overview of Cardiac Biomarkers for Cardiovascular Risk Stratification Chiadi Ndumele, MD | |
2:00 PM – 2:30 PM | Exhibit Hall Break | |
2:30 PM – 3:50 PM | Primetime CME Symposium Integrated Approach to Cardiorenal Management: Maximizing SGLT2 Inhibitor Benefits and Early Detection of HF and CKD Supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company. Chair: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC Presenters: Chiadi Ndumele, MD; Pam R. Taub, MD | |
3:50 PM – 5:00 PM | Challenging Cardiorenal Cases & Panel Discussion & Audience Questions Moderator: Keith C. Ferdinand, MD Panelists: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Chiadi Ndumele, MD; Ajay K. Singh, MBBS, FRCP, MBA | |
5:00 PM – 6:00 PM | Welcome Reception – Exhibit Hall | |
6:00 PM – 7:00 PM | PME Dinner Symposium (non-CME) Mounjaro® (tirzepatide) Product Theater Sponsored by Lilly. James W. Chu, MD, FACE | |
6:45 AM – 7:45 AM | PME Breakfast Symposium (non-CME) A Treatment Option for Patients with Heart Failure Sponsored by AstraZeneca. Suren Sivarajah, MD; Justin Fongemie, PharmD, BCCP | |
Session II: Obesity | ||
7:45 AM – 8:15 AM | Refresh and Recharge – Exhibit Hall Break | |
8:15 AM – 8:20 AM | Opening Remarks Robert H. Eckel, MD | |
8:20 AM – 8:40 AM | Delving into Behavioral Approaches to Manage Obesity for Optimum Cardiometabolic Health Sam Dagogo-Jack, MD, DSc, MBA | |
8:40 AM – 9:00 AM | Ultra-Processed Food Addiction: Signs and Solutions Erica M. LaFata, PhD | |
9:00 AM – 9:20 AM | Advances in Obesity Pharmacotherapy Louis J. Aronne, MD | |
9:20 AM – 9:40 AM | Sleep Disorders and Cardiometabolic Health Virend K. Somers, MD, PhD | |
9:40 AM – 10:00 AM | Challenges in Surgical Approaches to Obesity: Patient Selection, Procedures, Weight Regain Dimitrios Stefanidis, PhD, MD | |
10:00 AM – 11:05 AM | Primetime CME Symposium Addressing the Cardiometabolic Risk Continuum in MASH: What Clinicians Need to Know Supported by an educational grant from Novo Nordisk. In partnership with the Global Liver Institute. Diana Barb, MD; Mitchell L. Shiffman, MD | |
11:05 AM – 12:00 PM | Challenging Obesity Management Cases & Panel Discussion & Audience Questions Moderator: Robert H. Eckel, MD Panelists: Louis J. Aronne, MD; Sam Dagogo-Jack, MD, DSc, MBA; Erica M. LaFata, PhD; Dimitrios Stefanidis, PhD, MD; Virend K. Somers, MD, PhD | |
12:00 PM – 12:30 PM | Exhibit Hall Break | |
12:30 PM – 1:30 PM | PME Lunch Symposium (non-CME) Overcoming the Hurdles: Address CV Risk and Weight in Appropriate Patients Sponsored by Novo Nordisk. Matthew Budoff, MD | |
1:30 PM – 2:00 PM | Exhibit Hall Break | |
Session III: Diabetes | ||
2:00 PM – 2:05 PM | Opening Remarks Anne L. Peters, MD | |
2:05 PM – 2:25 PM | Precision Medicine in Diabetes Jose C. Florez, MD, PhD | |
2:25 PM – 2:45 PM | Expert Perspectives on Initiating and Maintaining Insulin Therapy in Type 2 Diabetes Patients Jay H. Shubrook, DO, FAAFP, FACOFP | |
2:45 PM – 3:05 PM | CGM in People Without Diabetes and CVD Risk Grazia Aleppo, MD, FACE, FACP | |
3:05 PM – 3:20 PM | Refresh and Recharge – Exhibit Hall Break | |
3:20 PM – 4:10 PM | Primetime CME Symposium | |
4:10 PM – 5:10 PM | Challenging Diabetes Management Cases & Panel Discussion & Audience Questions Moderator: Anne L. Peters, MD Panelists: Grazia Aleppo, MD, FACE, FACP; Jose C. Florez, MD, PhD; Jay H. Shubrook, DO, FAAFP, FACOFP | |
5:10 PM – 6:10 PM | Happy Hour & Giveaways – Exhibit Hall | |
6:15 PM – 7:15 PM | PME Dinner Symposium (non-CME) Product Theater for ZepboundTM (tirzepatide) Injection Sponsored by Lilly. Nicole Ciffone, MS, ANP-C, AACC, FNLA | |
Session IV: Dyslipidemia/Atherosclerosis/Thrombosis | ||
|---|---|---|
7:00 AM – 8:00 AM | PME Breakfast Symposium (non-CME) WAINUA: Overview of a Treatment Option for hATTR-PN Sponsored by AstraZeneca Rugmani Iyer, PhD | |
8:00 AM – 8:30 AM | Refresh and Recharge Break | |
8:30 AM – 8:30 AM | Opening Remarks Christie M. Ballantyne, MD | |
8:30 AM – 9:10 AM | LDL Lowering Therapy Beyond Statin Supported by an educational grant from Esperion Therapeutics. Pamela B. Morris, MD | |
9:10 AM – 9:35 AM | How to Improve Cardiovascular Outcomes in Women Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC | |
9:35 AM – 10:00 AM | Primary Prevention of CVD: The Sooner the Better? Erin D. Michos, MD | |
10:00 AM – 10:30 AM | Exploring Solutions for Severe Hypertriglyceridemia and FCS: Current Challenges and Progress Supported by an educational grant from Arrowhead Pharmaceuticals. Michael D. Shapiro, DO | |
10:30 AM – 11:00 AM | Understanding Lipoprotein(a): Implications for Cardiovascular Risk and Management Christie M. Ballantyne, MD | |
11:00 AM – 11:15 AM | Refresh and Recharge Break | |
11:15 AM – 12:35 PM | Challenging Lipid Management Cases & Panel Discussion & Audience Questions Moderator: Christie M. Ballantyne, MD Panelists: Robert H. Eckel, MD; Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC; Erin D. Michos, MD; Pamela B. Morris, MD; Michael D. Shapiro, DO | |
12:35 PM | Closing Remarks
Christie M. Ballantyne, MD | |
Apply for a Scholarship
CMHC extends the opportunity to dedicated students, fellows, and any clinicians-in-training interested in cardiometabolic medicine to apply for the George L. Bakris Scholarship Program in honor of CMHC Chair, George L. Bakris, MD, who was a strong supporter of education in cardiorenal metabolic medicine. Chosen applicants will receive complimentary registration and a two-night hotel stay at the 19th Annual Cardiometabolic Health Congress, the opportunity to personally meet with CMHC faculty, along with access to the Foundations of Cardiometabolic Health Certificate Course. Please click below for more information.
Abstract Submission
CMHC Chairpersons Christie M. Ballantyne, MD, Robert H. Eckel, MD, and Anne L. Peters, MD, invite you to submit scientific poster abstracts to be presented at the 2024 Cardiometabolic Health Congress (CMHC).
Registration
Conference Venue
Boston Park Plaza
50 Park Plaza, Boston, MA 02116
Â
- Room Rate: $397/night (expires 9-24-24)
- Phone: (617) 426-2000
